Search Results - "Bandera, Christina A"

Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients by Gagnon, Audrey, Kim, Jae-Hoon, Schorge, John O, Ye, Bin, Liu, Brian, Hasselblatt, Kathleen, Welch, William R, Bandera, Christina A, Mok, Samuel C

“…Purpose: Novel biomarkers are urgently needed to increase the sensitivity of CA125 for the early detection of ovarian cancer. Indeed, it has been shown that as…”
Get full text

Selenium binding protein 1 in ovarian cancer by Huang, Kuan‐Chun, Park, Dong Choon, Ng, Shu‐Kay, Lee, Ji Young, Ni, Xiaoyan, Ng, Wing‐Chung, Bandera, Christina A., Welch, William R., Berkowitz, Ross S., Mok, Samuel C., Ng, Shu‐Wing

“…Selenium binding protein 1 (SELENBP1) was identified to be the most significantly down‐regulated protein in ovarian cancer cells by a membrane proteome…”
Get full text

Cryoablation of Abdominal Wall Endometriosis: A Minimally Invasive Treatment by Dibble, Elizabeth H, D'Amico, Kelly C, Bandera, Christina A, Littrup, Peter J

“…The objective of this study is to present cryoablation as a minimally invasive definitive treatment for abdominal wall endometriosis. We describe our…”
Get full text

Vaginal Cuff Recurrence of Endometrial Cancer Treated by Laparoscopic-Assisted Vaginal Hysterectomy by Chu, Christina S., Randall, Thomas C., Bandera, Christina A., Rubin, Stephen C.

“…Background. Laparoscopic-assisted vaginal hysterectomy (LAVH) has been suggested as an alternative to total abdominal hysterectomy (TAH) for the treatment of…”
Get full text

New technologies for the identification of markers for early detection of ovarian cancer by Bandera, Christina A, Ye, Bin, Mok, Samuel C

“…The ovarian cancer screening regimens in current use fail to identify disease at an early curable stage. New technologies are emerging that facilitate the…”
Get full text

Robotic surgery in gynecologic oncology by Bandera, Christina A, Magrina, Javier F

“…Robotic surgery is rapidly taking the place of laparoscopy in many gynecologic oncology practices. Numerous practitioners have published their experience with…”
Get full text

Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary by Tsuda, Hiroshi, Bandera, Christina A, Birrer, Michael J, Hashiguchi, Yasunori, Berkowitz, Ross S, Mok, Samuel C

“…The purpose of this study is to compare DNA, mRNA and protein levels of the cyclin E between clear cell (CC) and serous (SC) ovarian carcinomas, and evaluate…”
Get more information

New Approaches to Improving Survival After Neoadjuvant Chemotherapy: The Role of Intraperitoneal Therapy and Heated Intraperitoneal Chemotherapy in Ovarian Cancer by Lopresti, Mary L, Bandera, Christina A, Miner, Thomas J

“…For women with newly diagnosed ovarian cancer, the goal of surgery is to achieve a maximal, if not complete, cytoreduction. In cases when this is not possible,…”
Get more information

Addressing clinical trials: Can the Multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program by Kuroki, Lindsay, Stuckey, Ashley, Hirway, Priya, Raker, Christina A, Bandera, Christina A, DiSilvestro, Paul A, Granai, Cornelius O, Legare, Robert D, Sakr, Bachir J, Dizon, Don S

“…Abstract Objective The Tumor Board (TB) allows for an interdisciplinary approach to cancer treatment designed to encourage evidence-based treatment. However,…”
Get full text

Advances in the understanding of risk factors for ovarian cancer by BANDERA, Christina A

“…The identification of risk factors for ovarian cancer is central to the goal of preventing deaths from this disease. Reproductive and hormonal history clearly…”
Get full text

Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum by BANDERA, C. A, MUTO, M. G, WELCH, W. R, BERKOWITZ, R. S, MOK, S. C

“…We extend the evaluation of allelic loss patterns on chromosome 17 to papillary serous carcinoma of the peritoneum (PSCP) which is histologically identical to…”
Get full text

Molecular Evidence for Multifocal Papillary Serous Carcinoma of the Peritoneum in Patients With Germline BRCA1 Mutations by Schorge, John O., Muto, Michael G., Welch, William R., Bandera, Christina A., Rubin, Stephen C., Bell, Debra A., Berkowitz, Ross S., Mok, Samuel C.

“…Papillary serous carcinoma of the peritoneum (PSCP) diffusely involves peritoneal surfaces, while it spares or only superficially involves the ovaries. PSCP is…”
Get full text

Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma by BANDERA, C. A, TAKAHASHI, H, BEHBAKHT, K, LIU, P. C, LIVOLSI, V. A, BENJAMIN, I, MORGAN, M. A, KING, S. A, RUBIN, S. C, BOYD, J

“…Previous allelotyping studies of epithelial ovarian carcinoma suggest that loss of heterozygosity on chromosome 14q may be a common genetic alteration in this…”
Get full text

Transvaginal ultrasonography of the endometrium in postmenopausal Japanese women by Tsuda, Hiroshi, Nakamura, Hiroaki, Inoue, Takeshi, Kawamura, Naoki, Adachi, Ken-ichi, Bandera, Christina A

“…To determine the cut-off level of endometrial thickness for detecting endometrial disease on a large scale of screening and to examine the usefulness of…”
Get more information

Mutations of the BRCA2 gene in ovarian carcinomas by TAKAHASHI, H, CHIU, H.-C, CARDONICK, A, BENJAMIN, I, MORGAN, M. A, KING, S. A, MIKUTA, J. J, RUBIN, S. C, BOYD, J, BANDERA, C. A, BEHBAKHT, K, LIU, P. C, COUCH, F. J, WEBER, B. L, LIVOLSI, V. A, FURUSATO, M, REBANE, B. A

“…Inherited mutations in the recently discovered BRCA2 gene are believed to be responsible for a significant fraction of early-onset hereditary breast cancers…”
Get full text

Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer by Hashiguchi, Yasunori, Tsuda, Hiroshi, Bandera, Christina A, Nishimura, Sadako, Inoue, Takeshi, Kawamura, Naoki, Berkowitz, Ross S, Mok, Samuel C

“…This study compared the DNA, RNA, and protein levels of osteopontin (OPN) in endometrioid endometrial cancer (EEC) and ovarian endometrioid cancer (OEC). In…”
Get full text

C-Kit Immunoreactivity in Endometrial Adenocarcinomas and Its Clinicopathologic Significance by Scobie, Janice V, Acs, Geza, Bandera, Christina A, Blank, Stephanie V, Wheeler, James E, Pasha, Teresa L, Salscheider, Marilyn, Zhang, Paul J

“…The proto-oncogene c-kit is a transmembrane–tyrosine-kinase receptor that is structurally related to the platelet-derived growth-factor receptor (PDGFR) and is…”
Get full text

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum by MUTO, M. G, WELCH, W. R, CHI-HO MOK, S, BANDERA, C. A, FISHBAUGH, P. M, SAI-WAH TSAO, LAU, C. C, GOODMAN, H. M, KNAPP, R. C, BERKOWITZ, R. S

“…Histopathological evidence suggests that papillary serous carcinoma of the peritoneum (PSCP) may be multifocal in origin. Utilizing a PCR based method to…”
Get full text

Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell lines by Bandera, Christina A, Tsui, Hing Wo, Mok, Samuel C, Tsui, Florence W

“…Ovarian carcinoma originates from the epithelial cells on the surface of the ovary. This study evaluates cytokine production by these cells. Normal human ovary…”
Get more information

Survival of BRCA1 Negative Ovarian Cancer Patients Based on Family History by Chu, Christina S., Morgan, Mark A., Randall, Thomas C., Bandera, Christina A., Rubin, Stephen C.

“…Objective. To compare survival of ovarian cancer patients with and without a family history of breast or ovarian cancer who are known to be without mutations…”
Get full text